Eight in Intensive Care
(JULY 17, 2020)
[Translation from the Russian:]
Four APU fighters died in Ukraine after receiving a coronavirus vaccine developed by American specialists. This was announced by the representative of the press service of the People’s Militia of the self-proclaimed Luhansk People’s Republic Alexander Mazeikin.
According to him, the drug is being tested in the Kharkiv region. Among the volunteers – 15 people, in particular, ten of them are infected with COVID-19.
In the study, eight patients’ health deteriorated sharply and they were transferred to intensive care. As a result, five patients, including four servicemen, died from complications caused by the infection, Mazeikin said. He stressed that doctors were unable to provide the necessary assistance to the victims because they did not have information about the composition of the injections.
He also noted that the vaccines, presumably, could be used in some medical institutions in the Kharkiv region, which caused complications in patients with weak immunity, according to the Luhansk Information Center. Earlier it became known that the American vaccine against COVID-19 has been tested on humans. A strong immune response to coronavirus was recorded in all 45 patients who participated in the first phase of the study.
The drug was created by the American biotechnology company Moderna. During clinical trials, patients received two doses of the potential vaccine, and all volunteers developed antibodies. The trials involved 45 healthy people aged 18 to 55 years. It is specified that each of the three groups received the mRNA-1273 vaccine in different dosages twice with an interval of 28 days.
Earlier NEWS.ru wrote that clinical trials of the vaccine, created by specialists of the Research Center (SIC) of Epidemiology and Microbiology named after NF Gamalei, began in Russia on June 18. Two groups of volunteers have already been vaccinated. They consist of contract soldiers and civilians.
Testing is carried out by specialists of the Main Military Clinical Hospital named after NN Burdenko and the State Medical University named after IM Sechenov.
In the second half of June, the head of the SIC Alexander Ginzburg said that the release of the Russian vaccine against coronavirus may begin in autumn 2020. Prior to that, Deputy Prime Minister Tatiana Golikova said that the start of production is expected in September. In August-September, manufacturers expect to register the drug.